Growth hormone (GH) deficiency is present in the majority of PWS cases (up to 74%) and is assessed through measuring the level of insulin-like growth factor 1 (IGF-1), the major mediator of GH [103,119,180]. This evidence concerns the gene IGF1 and Prader-Willi syndrome.